Back to Agenda
Session 13: Quality Assurance in Drug Development (GxPs)
Session Chair(s)
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
- Good Clinical Practices
- Sponsor Responsibilities
- Investigator Responsibilities
- Institutional Review Boards
- Informed Consent
- Good Laboratory Practices
- Good Manufacturing Practices
Have an account?